Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results from inspirADA
<h4>Background and Aims</h4> <p>Randomised trials have described the benefits of adalimumab [ADA] for ulcerative colitis [UC]; however, few data are available on health-related quality of life [HRQL] and health care costs in clinical practice.</p> <h4>Methods</h4>...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Published: |
Oxford University Press
2017
|
Search Result 1